Cargando…
Screening technologies for cervical cancer: Overview
Ever since the introduction of the Papanicolaou (PAP) smear test was published in 1941 in American Journal of Obstetrics and Gynecology, PAP test linked with definitive treatment has prevented millions of women from cervical cancer in the developed countries. Due to limited availability of resources...
Autores principales: | Banerjee, Dipanwita, Mittal, Srabani, Mandal, Ranajit, Basu, Partha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063504/ https://www.ncbi.nlm.nih.gov/pubmed/35510117 http://dx.doi.org/10.25259/CMAS_03_04_2021 |
Ejemplares similares
-
Role of colposcopy in the management of women with abnormal cytology
por: Hariprasad, Roopa, et al.
Publicado: (2022) -
Role of immunocytochemistry in cervical cancer screening
por: Shidham, Vinod B.
Publicado: (2022) -
Cervical Pre-cancers: Biopsy and Immunohistochemistry
por: Kamal, Meherbano
Publicado: (2022) -
The ‘Why and How’ of Cervical Cancers and Genital HPV Infection
por: Bhat, Dharitri
Publicado: (2022) -
Cervical Cancers: Varieties and the Lower Anogenital Squamous Terminology
por: Gadkari, Rasika, et al.
Publicado: (2022)